קיוואר 50 ישראל - עברית - Ministry of Health

קיוואר 50

abic marketing ltd, israel - beclometasone dipropionate - משאף - beclometasone dipropionate 50 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

קיוואר 100 ישראל - עברית - Ministry of Health

קיוואר 100

teva israel ltd - beclometasone dipropionate - משאף - beclometasone dipropionate 100 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

קיו-ואר 50 ישראל - עברית - Ministry of Health

קיו-ואר 50

abic marketing ltd, israel - beclometasone dipropionate - משאף - beclometasone dipropionate 50 mcg/dose - beclometasone

דיברסיד קרם ישראל - עברית - Ministry of Health

דיברסיד קרם

אס.טי. הלתליין בעמ - הקלה והרגעת שפשופים בפי הטבעת

קיו-ואר 100 ישראל - עברית - Ministry of Health

קיו-ואר 100

abic marketing ltd, israel - beclometasone dipropionate - משאף - beclometasone dipropionate 100 mcg/dose - beclometasone

קיו-ואר 100 ישראל - עברית - Ministry of Health

קיו-ואר 100

abic marketing ltd, israel - beclometasone dipropionate - משאף - beclometasone dipropionate 100 mcg/dose - beclometasone

Tevadaptor - Closed drug reconstitution system ישראל - עברית - Ministry of Health

tevadaptor - closed drug reconstitution system

teva medical ltd. - migada - אחות - see attached document : us fda 510(k) k051669 approved indications for use

טבעגרסטים ישראל - עברית - Ministry of Health

טבעגרסטים

teva israel ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 0.6 mg/ml - filgrastim - filgrastim - tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of tevagrastim are similar in adults and children receiving cytotoxic chemotherapy. tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc). in patients children or adults with severe congenital neutropenia cyclic or idiopathic neutropenia with an absolute nuetrophil count (anc) less than or equal to 0.5 x 1000000000 /l and a history of severe or recurrent infections long term administration of tevagrastim is indicated to increase neutophil count and to red

טבעקוטן ישראל - עברית - Ministry of Health

טבעקוטן

teva israel ltd - clotrimazole; dexamethasone acetate; neomycin sulfate - קרם - clotrimazole 1 %; dexamethasone acetate 0.044 %; neomycin sulfate 0.645 % - dexamethasone - dexamethasone - tevacutan is indicated for the treatment of mycotic infections of the skin complicated by inflammation and/or secondary infection.

קרוודילול טבע    6.25 מג ישראל - עברית - Ministry of Health

קרוודילול טבע 6.25 מג

teva israel ltd - carvedilol - טבליה - carvedilol 6.25 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.